Applied NeuroSolutions, Inc.’s Renews Agreement with Noted Alzheimer’s Disease Researcher, Peter Davies, Ph.D.
VERNON HILLS, Ill.--(BUSINESS WIRE)--Applied NeuroSolutions, Inc. (OTCBB:APNS)(www.AppliedNeuroSolutions.com), a Company focused on the development and commercialization of an integrated product portfolio for the treatment and diagnosis of Alzheimer’s disease (“AD”), today announced it has renewed its consulting agreement with Peter Davies, Ph.D., the Company’s founding scientist.